Remimazolam group
Remimazolam group is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
Comparison of Postoperative QoR-15 Scores Between Propofol and Remimazolam
Remimazolam Total Intravenous Anesthesia Under Analgesia Nociception Index-guidance
Clinical Trials (6)
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
Comparison of Postoperative QoR-15 Scores Between Propofol and Remimazolam
Remimazolam Total Intravenous Anesthesia Under Analgesia Nociception Index-guidance
The Comparison of Hemodynamic Effects Between Remimazolam-remifentanil and Propofol-remifentanil in Patients Undergoing Laparoscopic Cholecystectomy
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6